What’s at stake in the Supreme Court mifepristone case Legal scholars like Ziegler also note that there’s an even bigger way that this case could affect everyone in the country. “You have, lurking in the background, the possibility that the Comstock Act is going to be reinvented as an abortion ban,” she says. Read more … Read more
‘Cruel’: the supreme court could send one-time abortion deserts like Hawaii back in time If the supreme court rewinds these measures, many people will likely have to go to much greater lengths to end their pregnancies. The availability of abortion in the US would plummet, abortion providers and their supporters told the Guardian – even … Read more
A Supreme Court case over whether to tighten restrictions on mifepristone – one of two drugs used in the medication abortion regimen – could destabilize the American pharmaceutical industry, deterring companies from developing new drugs and even inspiring copycat lawsuits intended to revoke authorization of other politically contentious medications. Read more at 19th News
“They’re not legitimate medical groups sounding an alarm. They’re ideological organizations, basically registering a website and using it to roll back reproductive rights,” Caroline Ciccone, president of the watchdog group Accountable.Us, said Thursday. “Basically, it’s a contrived coalition of extremist groups.” Read more at HuffPost
Adkins’ concerns go to the heart of a problem that has bedeviled scientists for at least a decade: the judicial system’s repeated adoption of poor-quality evidence to justify litigation and legislation to restrict abortion. Often that evidence is produced by the anti-abortion movement itself. Read more at The Guardian
Next week, the court will hear arguments in a case that could restrict the use of mifepristone, which a growing number of Americans get without an in-person appointment. Read more at 19th News
Research at the heart of a federal case against the abortion pill has been retracted Sage, the publisher of the journal, retracted the study on Monday along with two other papers, explaining in a statement that “expert reviewers found that the studies demonstrate a lack of scientific rigor that invalidates or renders unreliable the authors’ … Read more
The Supreme Court on Monday set a date for one of the highest-stakes and closest-watched cases of the term — announcing it will hear oral arguments on how patients can access mifepristone, the commonly used abortion pill, on March 26. Read more at Politico
The appeals court ruling under review “threatens to destabilize the pharmaceutical industry, which relies both on FDA’s ability to make predictive judgments and on courts not second-guessing those scientific judgments,” the lawyers wrote. Read more at NBC News
“EMTALA is currently the only federal protection for patients who need emergency abortions. If the Supreme Court eviscerates that, there is no doubt that people will die,” Northup said in a statement. Read more at Rolling Stone
